Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/23/2003WO2003006654A3 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom
10/23/2003WO2003005888A3 Lipophilin complexes for use in cancer diagnosis and therapy
10/23/2003WO2003002602A3 Nogo and nogo receptor derived peptides for t-cell mediated neuroprotection
10/23/2003WO2002102312A3 Combination therapy of gamma-interferon and b cell specific antibodies
10/23/2003WO2002099099A3 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
10/23/2003WO2002097042A3 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
10/23/2003WO2002092015A3 Reagents and methods for modulating dkk-mediated interactions
10/23/2003WO2002090583A3 Skin treatment
10/23/2003WO2002083723A3 Polypeptides from h. influenzae homologous to a surface-exposed protein of neisseria meningitidis
10/23/2003WO2002081745A3 Genes involved in osteogenesis, and methods of use
10/23/2003WO2002081521A8 Osteoprotegerin in milk
10/23/2003WO2002081519A3 Ifn-thy fusion protein,dna coding therefore,its preparation and application
10/23/2003WO2002081518A3 Proteins, polynucleotides encoding them and methods of using the same
10/23/2003WO2002081505A3 Peptide for the diagnosis and therapy of alzheimer's disease
10/23/2003WO2002077216A3 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/23/2003WO2002077199A3 Methods and products related to fgf dimerization
10/23/2003WO2002070646A3 Matrix stabilized enzyme crystals and methods of use
10/23/2003WO2002070556A9 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF
10/23/2003WO2002066989A3 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms
10/23/2003WO2002066494A8 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
10/23/2003WO2002055536A3 Regulation of target protein activity through modifier proteins
10/23/2003WO2002048173A3 Expression of a cadherin-like protein in benign prostatic hyperplasia
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2002044321A3 Rna interference mediating small rna molecules
10/23/2003WO2002036806A3 Expression vectors able to elicit improved immune response and methods of using same
10/23/2003WO2002036630A3 Renin and/or proprenin receptor protein, nucleic acid coding for same and uses thereof
10/23/2003WO2002036145A8 Kahalalide f formulation
10/23/2003WO2001096376A9 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
10/23/2003WO2001079267A9 A glycopeptide and preparation thereof
10/23/2003WO2001079195A9 Pyridine and pyrazine derivatives as thrombin inhibitors
10/23/2003WO2001068805A3 Human olfactory receptors and genes encoding same
10/23/2003WO2001066763A9 23436, a human ubiquitin protease family member and uses thereof
10/23/2003WO2001055337A9 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/23/2003WO2001040519A8 Methods for identifying modulators for balance related disorders
10/23/2003WO2001009328A8 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/23/2003WO2001005427A8 Psca: prostate stem cell antigen and uses thereof
10/23/2003WO2001002567A8 16405 receptor, a g-protein coupled receptor
10/23/2003WO2001000879A8 Novel kinases and uses thereof
10/23/2003WO2001000812A8 22012, a novel human carboxypeptidase
10/23/2003WO2001000811A8 17867, a novel human aminopeptidase
10/23/2003US20030200555 For Alzheimer's disease diagnosis, treatment
10/23/2003US20030199683 For diagnosing and treating related disorders
10/23/2003US20030199679 Recombinant antibodies specific for TNF-alpha
10/23/2003US20030199678 Such that binding modifies TNF activity
10/23/2003US20030199677 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
10/23/2003US20030199676 Effective for proteins expressed in bacteria as inclusion bodies
10/23/2003US20030199675 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199674 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/23/2003US20030199673 For inducing immune response and administering immunotherapy
10/23/2003US20030199672 Mixture of glucagon-like peptide-I (GLP-1) having a lipophilic substituent such as N-epsilon-tetradecanoyllysine, and a surfactant; treating obesity and non insulin-dependent diabetes mellitus (NIDDM); protracted profile of action
10/23/2003US20030199568 Salt of perindopril and pharmaceutical compositions containing it
10/23/2003US20030199561 Boronic ester and acid compounds, synthesis and uses
10/23/2003US20030199557 Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
10/23/2003US20030199535 Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
10/23/2003US20030199506 An enzyme inhibitor of cysteine proteases, a morpholine-4-carboxyamide 1,3,4-oxadiazole derivatives; for treating arthritis, muscular dystrophy, inflammation, tumor, glomerulonephritis, malaria, periodontal disease
10/23/2003US20030199498 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
10/23/2003US20030199496 Pharmaceutical compositions containing alpha3beta4 nicotinic receptor antagonists and methods of their use
10/23/2003US20030199492 Combination therapy
10/23/2003US20030199477 Use of gellable pharmaceutical compositions in periodontology
10/23/2003US20030199472 Administering to the patient an effective amount of an expression construct comprising nucleic acid comprising a sequence encoding a modified estrogen receptor, wherein sequence is under control of promoter
10/23/2003US20030199471 For use in medicaments
10/23/2003US20030199470 Determining the status of 158P1D7 gene products expressed by cells in a tissue sample; comparing the status so determined to the status of 158P1D7 gene products in normal sample; identifying the presence of aberrant 158P1D7 gene products
10/23/2003US20030199467 Antisense modulation of human Rho family gene expression
10/23/2003US20030199465 For detection and therapy of a broad range of pathological states
10/23/2003US20030199464 Regeneration of endogenous myocardial tissue by induction of neovascularization
10/23/2003US20030199463 For therapy of cardiovascular disease, fibrotic disease
10/23/2003US20030199455 Thrombolytic agents, restenosis, hypotension agents, heart failure, antiarrhythmia and -inflammation agents, angina, stroke, atherosclerosis, antiischemic agents, angiogenesis related disorders, anti carcinogenic and -tumor agents
10/23/2003US20030199452 Antigenic peptides reacting with anti-ovary antibodies
10/23/2003US20030199450 Regulation of cytokine synthesis and release
10/23/2003US20030199449 Combination of ablation and controlled drug delivery for the treatment of cancer
10/23/2003US20030199448 Treatment of skin conditions
10/23/2003US20030199447 Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
10/23/2003US20030199445 Use of GLP-1 compound for treatment of critically ill patients
10/23/2003US20030199444 Comprising a preparation of Blood Factor VII or a Factor VII-related polypeptide and a preparation of factor VIII (antihemophilic factor) or a factor VIII-related polypeptide; high speed coagulants in one dosage form; kits; hemostatis
10/23/2003US20030199443 Novel FGF homologs
10/23/2003US20030199441 Procollagen (III) Propeptides and Related Substances for Treating Fibrotic Diseases
10/23/2003US20030199440 Comprises a growth factor and an enzyme inhibitor for a specific adverse enzyme that is upregulated in the environment of a damaged tissue; wound healing agents; antiulcer agents; chronic wounds, e.g. decubitus ulcers
10/23/2003US20030199439 Compositions of alpha3beta4 receptor antagonists and opioid agonist analgesics
10/23/2003US20030199437 Identification, isolation and recombinant production of novel DNA; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules; fused heterologous polypeptide sequences, binding antibodies; anticarcinogenic
10/23/2003US20030199436 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199435 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199434 Proliferation of chondrocytes to increase the biosynthesis of collagen administering angiotensinogen, angiotensin I and II including analogues, fragments and analogues and type 2 receptor agonists; amino acid sequences; kits
10/23/2003US20030199433 Pharmaceutical composition
10/23/2003US20030199431 Modified peptide nucleic acid (PNA) molecules
10/23/2003US20030199429 Use of heregulin as a growth factor
10/23/2003US20030199428 Identifying a thrombin generation time for a blood sample to assess risk of bleeding, to diagnose various disorders, and to monitor the effects of pharmaceutical and other treatments.
10/23/2003US20030199427 Increased or improved bioavailability of the active agent
10/23/2003US20030199423 ICAM-related protein
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199091 Compositions and methods for enhancing oligonucleotide-mediated gene alteration
10/23/2003US20030199073 Production of recombinant human lysosomal alpha-mannosidase
10/23/2003US20030199067 Growth arrest homeobox gene
10/23/2003US20030199064 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199063 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199062 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199061 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199060 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199059 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199058 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199057 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 ... 3163